Actively Recruiting
Italian iTTP Registry
Led by Fondazione Luigi Villa · Updated on 2024-07-10
132
Participants Needed
1
Research Sites
310 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
ItaliTTP is an observational, prospective, single-arm, national, multicenter, non-pharmacological cohort study aimed at better defining and understanding the natural history, disease severity, and clinical outcomes of patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP) in Italy. A minimum of 132 consecutive patients with acute iTTP (first event or relapse) will be enrolled for 3 years, with the possibility of extension, with a follow-up period of 3 years.
CONDITIONS
Official Title
Italian iTTP Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with an acute iTTP episode (first event or relapse), defined by thrombocytopenia and microangiopathic hemolytic anemia, with severe deficiency of ADAMTS13 activity (< 10 IU/dL or <10% of normal) and anti-ADAMTS13 autoantibodies
- Both male and female patients aged 12 years or older
- Patients who have signed informed consent to participate in the study
You will not qualify if you...
- Patients who have not signed informed consent to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, MI, Italy, 20122
Actively Recruiting
Research Team
S
Sandra Maccarone
CONTACT
I
Ilaria Mancini, MSc, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here